Literature DB >> 12767415

The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences.

Jim Young1, Heiner Bucher, Peter Tschudi, Pierre Périat, Christa Hugenschmidt, Antje Welge-Lüssen.   

Abstract

In a randomized double-blind trial 251 adults with sinusitis-like symptoms were given amoxicillin/clavulanate or placebo for 6 days. Seven diagnostic indicators for acute bacterial rhinosinusitis are compared by their accuracy assuming a latent class model and by the treatment effect that they would have had if used to select a subset of patients for antibiotic treatment. Under a latent class model, radiography is a more efficient indicator then C reactive protein (CRP), which is, in turn, more efficient than other clinical signs and symptoms. However, a history of purulent nasal discharge, and signs of pus in the nasal cavity and throat, are better criteria than radiography or CRP for selecting those patients who will benefit from antibiotic treatment. These contradictory results are a salutary reminder that diagnostic indicators need to be evaluated in terms of therapeutic consequences for the patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767415     DOI: 10.1016/s0895-4356(02)00590-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  The contribution of flexible endoscopy for diagnosis of acute bacterial rhinosinusitis.

Authors:  Gilead Berger; Rachel L Berger
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-08       Impact factor: 2.503

2.  Predicting prognosis and effect of antibiotic treatment in rhinosinusitis.

Authors:  An De Sutter; Marieke Lemiengre; Georges Van Maele; Mieke van Driel; Marc De Meyere; Thierry Christiaens; Jan De Maeseneer
Journal:  Ann Fam Med       Date:  2006 Nov-Dec       Impact factor: 5.166

Review 3.  Diagnosis of acute rhinosinusitis in primary care: a systematic review of test accuracy.

Authors:  Mark H Ebell; Brian McKay; Ryan Guilbault; Yokabed Ermias
Journal:  Br J Gen Pract       Date:  2016-08-01       Impact factor: 5.386

4.  Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial.

Authors:  Jochen W L Cals; Marjolein J C Schot; Sanne A M de Jong; Geert-Jan Dinant; Rogier M Hopstaken
Journal:  Ann Fam Med       Date:  2010 Mar-Apr       Impact factor: 5.166

5.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

Review 6.  Inflammatory Biomarkers During Bacterial Acute Rhinosinusitis.

Authors:  Timo J Autio; Timo Koskenkorva; Petri Koivunen; Olli-Pekka Alho
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

7.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

8.  C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis.

Authors:  Lars Bjerrum; Bente Gahrn-Hansen; Anders P Munck
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

9.  Short-course, low-dose oral betamethasone as an adjunct in the treatment of acute infective sinusitis : a comparative study with placebo.

Authors:  N P Ratau; J R Snyman; C Swanepoel
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 10.  Treatment options for acute sinusitis in children.

Authors:  Despina G Contopoulos-Ioannidis; John P A Ioannidis
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.